Skip to main content

Advertisement

Fig. 6 | Cell & Bioscience

Fig. 6

From: Label-free quantitative proteomics identifies transforming growth factor β1 (TGF-β1) as an inhibitor of adipogenic transformation in OP9-DL1 cells and primary thymic stromal cells

Fig. 6

IWR-1, a small molecule inhibitor of the Wnt/β-catenin pathway, restored the inhibitory effects of TGF-β1 on OP9-DL1 adipocyte differentiation. OP9-DL1 cells were treated with rosiglitazone and TGF-β1 in the presence of IWR-1 for 7 days, and accumulated lipids were visualized by Oil Red O staining. Bars, 50 μM. Rosi rosiglitazone

Back to article page